These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4608340)

  • 41. [Type II Charcot-Marie-Tooth and dopa-sensitive Parkinson disease].
    Tranchant C; Ruh D; Warter JM
    Rev Neurol (Paris); 1994; 150(1):72-4. PubMed ID: 7801046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experimental results of the combined treatment of parkinsonism using L-DOPA and a decarboxylase inhibitory agent (Ro 4-4602)].
    Birkmayer W
    Wien Klin Wochenschr; 1969 Sep; 81(39):677-9. PubMed ID: 5344299
    [No Abstract]   [Full Text] [Related]  

  • 43. Computational analysis of open loop handwriting movements in Parkinson's disease: a rapid method to detect dopamimetic effects.
    Eichhorn TE; Gasser T; Mai N; Marquardt C; Arnold G; Schwarz J; Oertel WH
    Mov Disord; 1996 May; 11(3):289-97. PubMed ID: 8723147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. L-dopa in the treatment of Parkinsonism.
    Brezný I; Buranová D; Cernácek J; Trávniková M
    Act Nerv Super (Praha); 1972; 14(2):96. PubMed ID: 5040182
    [No Abstract]   [Full Text] [Related]  

  • 45. The recording of Romberg' test and its application in neurology.
    Njiokiktjien C; de Rijke W
    Agressologie; 1972; 13():Suppl C:1-7. PubMed ID: 5080658
    [No Abstract]   [Full Text] [Related]  

  • 46. Loss of postural reflexes in long-term occupational solvent exposure.
    Kuriwaka R; Mitsui T; Fujiwara S; Nishida Y; Matsumoto T
    Eur Neurol; 2002; 47(2):85-7. PubMed ID: 11844896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Normal values and precision of a computerized test for evaluating postural control in man].
    Franchignoni FP; Vanni G; Savoini C
    Acta Otorhinolaryngol Ital; 1984; 4(2):175-83. PubMed ID: 6475531
    [No Abstract]   [Full Text] [Related]  

  • 48. [Analysis of the effects of L-dopa during a 3-month course of treatment].
    Pinto F; Venturini E
    Riv Neurobiol; 1970; 16(4):415-28. PubMed ID: 4949926
    [No Abstract]   [Full Text] [Related]  

  • 49. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA; De la Herrán J
    Rev Clin Esp; 1970 Dec; 119(6):555-62. PubMed ID: 5509794
    [No Abstract]   [Full Text] [Related]  

  • 50. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract]   [Full Text] [Related]  

  • 51. Parkinson's disease: L-dopa treatment and handwriting area.
    Knopp W; Paulson G; Allen JN; Smeltzer D; Brown FD; Kose W
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):115-25. PubMed ID: 4985489
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of patients with vascular parkinsonism with the preparations nakom and madopar].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1984 Apr; 62(4):112-6. PubMed ID: 6737958
    [No Abstract]   [Full Text] [Related]  

  • 53. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].
    Fischer PA
    Nervenarzt; 1974 Dec; 45(12):617-27. PubMed ID: 4614096
    [No Abstract]   [Full Text] [Related]  

  • 55. L-DOPA treatment for Parkinsonism: analysis of functional improvement.
    Jonas S
    Arch Phys Med Rehabil; 1971 Dec; 52(12):560-2. PubMed ID: 5136441
    [No Abstract]   [Full Text] [Related]  

  • 56. [Disturbance of equilibrium in Parkinsonism -- analysis of response to pushing chest (author's transl)].
    Nakano T; Yanagisawa N; Tsukagoshi H
    Rinsho Shinkeigaku; 1980 Nov; 20(11):924-32. PubMed ID: 7249474
    [No Abstract]   [Full Text] [Related]  

  • 57. Parkinsonism and dystonia, pseudo-parkinsonism and pseudodystonia.
    Quinn NP
    Adv Neurol; 1993; 60():540-3. PubMed ID: 8420187
    [No Abstract]   [Full Text] [Related]  

  • 58. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.
    Gerlach J; Reisby N; Randrup A
    Psychopharmacologia; 1974 Jan; 34(1):21-35. PubMed ID: 4593518
    [No Abstract]   [Full Text] [Related]  

  • 59. [A program for evaluation of stabilographic recordings using a microcomputer].
    Kundrát J; Hlavacka F
    Cesk Fysiol; 1989; 38(2):123-9. PubMed ID: 2736639
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of cholinopotentiating and cholinoblocking substances on the stable pathologic state in experimental epileptogenesis and parkinsonism].
    Losev NA; Tkachenko EI; Shalkovskaia LN
    Vestn Akad Med Nauk SSSR; 1985; (9):23-31. PubMed ID: 4060871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.